---
title: "linagliptin - Diabetes mellitus type 2"
sidebar: mydoc_sidebar
permalink: linagliptindiabetesmellitustype2.html
toc: false 
---

{% include image.html url="images/linagliptindiabetesmellitustype2.png" file="linagliptindiabetesmellitustype2.png" alt="linagliptindiabetesmellitustype2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069476 | linagliptin | Drug |
| UniProt:P27487 | DPP-4 | Protein |
| UniProt:P01275 | glucagon-like peptide 1 | Protein |
| MESH:D007328 | insulin | ChemicalSubstance |
| CL:0000169 | pancreatic B-cell | Cell |
| MESH:D005947 | glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Linagliptin | DECREASES ACTIVITY OF | Dpp-4 |
| Dpp-4 | INCREASES ACTIVITY OF | Glucagon-Like Peptide 1 |
| Glucagon-Like Peptide 1 | POSITIVELY REGULATES | Insulin |
| Insulin | LOCATED IN | Pancreatic B-Cell |
| Pancreatic B-Cell | DECREASES ABUNDANCE OF | Glucose |
| Glucose | TREATS | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB08882#mechanism-of-action](https://go.drugbank.com/drugs/DB08882#mechanism-of-action){:target="_blank"}